Zoledronic acid for the treatment of bone Metastases in patients with breast cancer and other solid tumors

被引：37
|
作者：
Lacerna, L [1 ]
Hohneker, J [1 ]
机构：
[1] Novartis Pharmaceut, Med Affairs, E Hanover, NJ 07936 USA
来源：
SEMINARS IN ONCOLOGY | 2003年 / 30卷 / 05期
关键词：
D O I：
10.1053/j.seminoncol.2003.08.017
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：150 / 160
页数：11
相关论文
共 50 条
  • [31] Denosumab versus zoledronic acid for the treatment of breast cancer patients with bone metastases: results of a randomized phase 3 study
    Stopeck, A.
    Body, J. J.
    Fujiwara, Y.
    Lipton, A.
    Steger, G. G.
    Viniegra, M.
    Fan, M.
    Braun, A.
    Dansey, R.
    Jun, S.
    [J]. EJC SUPPLEMENTS, 2009, 7 (03): : 2 - 3
  • [32] The ZOTECT study: Effect of zoledronic acid on bone metabolism in patients with bone metastases from prostate or breast cancer
    Hadji, Peyman
    Ziller, May
    Maurer, Tobias
    Autenrieth, Michael
    Muth, Mathias
    Ruebel, Amelie
    May, Christoph
    Birkholz, Katrin
    Diebel, Erhardt
    Gleissner, Jochen
    Rothe, Peter
    Gschwend, Juergen E.
    [J]. JOURNAL OF BONE ONCOLOGY, 2012, 1 (03) : 88 - 94
  • [33] Effects of zoledronic acid on serum levels of MMPs and bone remodeling markers in breast cancer patients with bone metastases
    Kanakis, I
    Nikolaou, M
    Kiamouris, C
    Pectasides, D
    Karamanos, N
    [J]. FEBS JOURNAL, 2005, 272 : 270 - 270
  • [34] Treatment of Bone Metastases in Lung Cancer: The Actual Role of Zoledronic Acid
    Ricciardi, Serena
    de Marinis, Filippo
    [J]. REVIEWS ON RECENT CLINICAL TRIALS, 2009, 4 (03) : 205 - 211
  • [35] Zoledronic acid and skeletal complications in patients with solid tumors and bone metastases - Analysis of a national medical claims database
    Hatoum, Hind T.
    Lin, Swu-Jane
    Smith, Mathew R.
    Barghout, Victoria
    Lipton, Allan
    [J]. CANCER, 2008, 113 (06) : 1438 - 1445
  • [36] Treatment of Bone metastases with Denosumab at Patients with solid Tumors
    Raunik, W.
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2012, 188 : 188 - 188
  • [37] LONG-TERM SAFETY OF ZOLEDRONIC ACID FOR BREAST CANCER WITH BONE METASTASES
    Taira, Shinichiro
    Takahashi, Shunji
    Ito, Yoshinori
    Tokudome, Nahomi
    Tsutsumi, Chizuko
    Kobayashi, Kokoro
    Fukuda, Takayo
    Asai, Hiroaki
    Oto, Masahumi
    Ito, Mayuko
    Hatake, Kiyohiko
    [J]. ANNALS OF ONCOLOGY, 2010, 21 : 21 - 21
  • [38] Effect of Denosumab Versus Zoledronic Acid Treatment in Patients with Breast Cancer and Bone Metastases: Results from the Extended Blinded Treatment Phase
    Stopeck, A.
    Martin, M.
    Ritchie, D.
    Body, J-J
    Paterson, A.
    Viniegra, M.
    Jassem, J.
    Takano, T.
    Van Poznak, C.
    Bourgeois, H.
    Fan, M.
    Dansey, R.
    Braun, A.
    [J]. CANCER RESEARCH, 2010, 70
  • [39] Denosumab and zoledronic acid treatment in patients with genitourinary cancers and bone metastases
    Costa, Luis
    Fizazi, Karim
    Saad, Fred
    Brown, Janet Elizabeth
    Von Moos, Roger
    Oudard, Stephane
    Sternberg, Cora N.
    Ganju, Vinod
    Miller, Kurt
    Wang, Huei
    Maniar, Tapan
    Braun, Ada
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [40] Slow zoledronic acid releasing testis prostheses in the treatment of prostate cancer patients with bone metastases
    Serefoglu, Ege Can
    Balbay, M. Derya
    [J]. MEDICAL HYPOTHESES, 2009, 73 (03) : 387 - 388
12345